ARAY
ACCURAY INC
NASDAQ · Healthcare · Medical - Devices · US
$0.23
−3.07%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.24
From 52W high−87.37%
Volume417024.00
Market cap$27.90M
P/E (TTM)—
P/S (TTM)0.1x
Div yield—
Key dataSep 18, 2026
Open
$0.24
From 52W high
−87.37%
Volume
417024.00
Market cap
$27.90M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−11.9x
P/E (TTM)
—
RSI (14)
39.4
MomentumView details →
1D Return
−3.07%
YTD Return
−71.62%
SummaryUpdated Jun 1, 2026
Accuray Incorporated (NASDAQ:ARAY) is a medical device company founded in 1990 and headquartered in Madison, Wisconsin. The company went public in February 2007 and specializes in designing, developing, manufacturing, and selling advanced radiosurgery and radiation therapy systems for cancer treatment. Accuray serves hospitals and treatment facilities globally, with operations spanning the United States, Canada, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific region. The company has established itself as a key player in the precision radiation therapy market, with over 1,000 systems installed worldwide.
Similar companies
Latest newsMore news →
Accuray Incorporated and RaySearch Laboratories AB entered into a definitive agreement for an expanded collaboration to integrate RayStation software with Accuray platforms and accelerate Accuray's online adaptive radiation therapy capabilities.9d agoAccuray Inc reported Q4 2026 revenue of $100.9 million, down 21% year-over-year, with a net loss of $1.9 million and diluted EPS of -$0.02.33d ago